Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond

Saghir Ali; Xiaochen Tian; Kathryn A. Cunningham; Jia Zhou

doi:10.1021/acs.jmedchem.5c01156

Targeting the 5-HT_2A Receptor for Developing Psychedelic Drugs and Beyond

Saghir Ali
, Xiaochen Tian
, Kathryn A. Cunningham
, Jia Zhou

Pharmacology & Toxicology

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	9831-9835
Number of pages	5
Journal	Journal of medicinal chemistry
Volume	68
Issue number	10
DOIs	https://doi.org/10.1021/acs.jmedchem.5c01156
State	Published - May 22 2025

ASJC Scopus subject areas

Molecular Medicine
Drug Discovery

Access to Document

10.1021/acs.jmedchem.5c01156

Cite this

@article{647f1f97bff2450f9cf2989143d9d75e,

title = "Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond",

author = "Saghir Ali and Xiaochen Tian and Cunningham, \{Kathryn A.\} and Jia Zhou",

year = "2025",

month = may,

day = "22",

doi = "10.1021/acs.jmedchem.5c01156",

language = "English (US)",

volume = "68",

pages = "9831--9835",

journal = "Journal of medicinal chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "10",

}

TY - JOUR

T1 - Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond

AU - Ali, Saghir

AU - Tian, Xiaochen

AU - Cunningham, Kathryn A.

AU - Zhou, Jia

PY - 2025/5/22

Y1 - 2025/5/22

UR - https://www.scopus.com/pages/publications/105005796473

UR - https://www.scopus.com/pages/publications/105005796473#tab=citedBy

U2 - 10.1021/acs.jmedchem.5c01156

DO - 10.1021/acs.jmedchem.5c01156

M3 - Editorial

C2 - 40400369

AN - SCOPUS:105005796473

SN - 0022-2623

VL - 68

SP - 9831

EP - 9835

JO - Journal of medicinal chemistry

JF - Journal of medicinal chemistry

IS - 10

ER -

Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Targeting the 5-HT_2A Receptor for Developing Psychedelic Drugs and Beyond